Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis
Fetal Diagnosis and Therapy · 21.07.2026 · 1-7
DOI: 10.1159/000553637 ↗Kurz gefasst
Fachartikel in der Zeitschrift Fetal Diagnosis and Therapy, online erschienen am 21.07.2026. Verfasst von K Aparna Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India. Die Arbeit nennt 14 Literaturangaben.
Abstract (Originalsprache)
Introduction
Rh isoimmunization remains a major cause of haemolytic disease of the fetus and newborn, particularly when fetal anaemia develops early in gestation. Antenatal intravenous immunoglobulin (IVIG) has been proposed to improve fetal outcomes, but evidence remains limited, especially from low- and middle-income settings.
Methods
This study was conducted at a tertiary care centre in India and included pregnant women with severe anti-D isoimmunization managed between 2023 and 2025. Inclusion criteria were pregnant women, with a previous pregnancy complicated by hydrops with perinatal death and/or requirement of intrauterine transfusion (IUT) before 24 weeks. They received antenatal IVIG (1 g/Kg/week from 13 to 14 weeks for 4–6 doses) and were compared with cases managed without IVIG. Outcomes analysed included presence of fetal hydrops, the requirement for IUT and the total number of IUTs, gestational age at first IUT, gestational age at delivery, and pregnancy outcome (live birth, stillbirth, or abortion) and neonatal outcomes.
Results
Thirty-four pregnancies were included with17 managed with IVIG and 17 managed without IVIG based on the timing of referral. The incidence of fetal hydrops was significantly lower in the IVIG group (5.9% vs. 52.9%, p = 0.008), and preterm delivery occurred less frequently (70.5% vs. 100%, p = 0.04). The need for IUT, gestational age at first IUT, number of IUTs, gestational age at delivery, and birth weight were comparable between groups. Live birth rate and survival at discharge were higher in the IVIG group, though differences did not reach statistical significance. Infusion-related reactions occurred in 17.6% of IVIG-treated patients and were mild.
Conclusion
Antenatal IVIG was associated with reduced fetal hydrops and preterm delivery in severe Rh isoimmunized pregnancies. However, these findings should be interpreted with caution as improved outcomes may also reflect earlier referral, surveillance, and intervention.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India.
- Department of Obstetrics and Gynaecology, All India Institute of Medical Sciences, New Delhi, India, tanishagupta.tanu@gmail.com.
Zitieren
APA
Sharma, K. A., Dadhwal, V., Gupta, T., & Rana, A. (2026). Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis. Fetal Diagnosis and Therapy, 1-7. https://doi.org/10.1159/000553637
Vancouver
Sharma KA, Dadhwal V, Gupta T, Rana A. Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis. Fetal Diagnosis and Therapy. 2026:1-7. doi:10.1159/000553637
BibTeX
@article{Sharma2026,
author = {Sharma, K Aparna and Dadhwal, Vatsla and Gupta, Tanisha and Rana, Anubhuti},
title = {Role of Antenatal IVIG in Improving Fetal Outcomes in Rh Isoimmunized Pregnancies: A Single-Centre Analysis},
journal = {Fetal Diagnosis and Therapy},
year = {2026},
pages = {1--7},
doi = {10.1159/000553637}
}
EUVIMED